Homocarbonyltopsentin (PK4C9) is a small-molecule compound that binds to TSL2, stabilizes its pentaloop conformation, and promotes its transition to a cloverleaf conformation, thereby enhancing SMN2 exon 7 (E7) inclusion during splicing (EC50 = 16 μM); it reduces the expression of E7-excluding SMN2 isoforms by up to 5.2-fold and increases E7-including isoforms by up to three-fold in GM03813C spinal muscular atrophy (SMA) cells; it also increases SMN protein expression by 1.5-fold in SMA cells compared to DMSO-treated controls.